US Stock MarketDetailed Quotes

Milestone Pharmaceuticals (MIST)

Watchlist
  • 1.890
  • +0.020+1.07%
Close Apr 24 15:59 ET
  • 1.900
  • +0.010+0.52%
Post 19:56 ET
222.39MMarket Cap-2.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Milestone Pharmaceuticals (MIST) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-70.00%-49.04M
-86.69%-12.78M
-38.90%-9.75M
-107.60%-12.57M
-56.17%-13.95M
37.86%-28.85M
30.14%-6.84M
42.29%-7.02M
42.70%-6.05M
35.75%-8.93M
Net income from continuing operations
-51.88%-63.06M
-40.82%-17.41M
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
30.44%-41.52M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
Operating gains losses
----
----
----
----
----
--8K
--0
--0
----
----
Depreciation and amortization
8.57%114K
30.77%34K
0.00%25K
7.69%28K
-3.57%27K
14.13%105K
0.00%26K
4.17%25K
8.33%26K
55.56%28K
Other non cash items
7.23%3.84M
7.30%985K
7.20%968K
7.22%951K
7.22%935K
40.17%3.58M
7.12%918K
7.24%903K
--887K
--872K
Change In working capital
-26.59%2.68M
-98.04%63K
-133.17%-69K
-267.29%-1.89M
609.12%4.58M
194.13%3.66M
182.86%3.22M
126.36%208K
-46.51%1.13M
26.01%-899K
-Change in receivables
-176.51%-1.12M
-483.09%-2M
43.48%495K
158.74%158K
-86.68%230K
155.34%1.46M
80.52%-343K
166.99%345K
-150.47%-269K
292.96%1.73M
-Change in inventory
---648K
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
-97.83%29K
12.15%766K
-125.80%-1.83M
147.77%1.61M
-163.24%-516K
-52.67%1.34M
-81.95%683K
48.11%-810K
1,280.85%649K
46.24%816K
-Change in payables and accrued expense
406.51%4.43M
-32.41%1.95M
88.31%1.27M
-585.77%-3.65M
241.78%4.87M
-15.54%875K
418.47%2.88M
-47.88%676K
-50.59%752K
-290.44%-3.43M
-Change in other working capital
29.41%-12K
---1K
-166.67%-8K
--0
70.00%-3K
-194.44%-17K
--0
70.00%-3K
-157.14%-4K
-1,100.00%-10K
Cash from discontinued investing activities
Operating cash flow
-70.00%-49.04M
-86.69%-12.78M
-38.90%-9.75M
-107.60%-12.57M
-56.17%-13.95M
37.86%-28.85M
30.14%-6.84M
42.29%-7.02M
42.70%-6.05M
35.75%-8.93M
Investing cash flow
Cash flow from continuing investing activities
35.77%11.25M
-86.02%2.7M
-639.79%-34.98M
4.87%9.94M
224.32%33.58M
74.16%8.28M
41.37%19.33M
159.69%6.48M
133.83%9.48M
-190.14%-27.01M
Net PPE purchase and sale
-815.15%-302K
-1,186.36%-283K
50.00%-2K
-57.14%-11K
---6K
70.54%-33K
29.03%-22K
77.78%-4K
77.42%-7K
--0
Net investment purchase and sale
38.86%11.55M
-84.57%2.99M
-639.43%-34.98M
4.91%9.96M
224.34%33.59M
70.83%8.32M
41.21%19.36M
159.83%6.49M
133.89%9.49M
-190.05%-27.01M
Cash from discontinued investing activities
Investing cash flow
35.77%11.25M
-86.02%2.7M
-639.79%-34.98M
4.87%9.94M
224.32%33.58M
74.16%8.28M
41.37%19.33M
159.69%6.48M
133.83%9.48M
-190.14%-27.01M
Financing cash flow
Cash flow from continuing financing activities
166.28%85.53M
151,704.17%36.43M
66,005.41%48.92M
112.08%36K
-99.57%140K
-32.79%32.12M
2,300.00%24K
-75.74%74K
89.23%-298K
-35.69%32.32M
Net issuance payments of debt
----
----
----
----
----
--0
--0
--0
--0
--0
Net common stock issuance
87.13%51.01M
--4.95M
--46.06M
--0
--0
--27.26M
--0
--0
---280K
--27.54M
Proceeds from stock option exercised by employees
610.10%34.52M
131,095.83%31.49M
3,758.11%2.86M
300.00%36K
-97.07%140K
746.86%4.86M
2,300.00%24K
-75.74%74K
-220.00%-18K
1,789.72%4.78M
Cash from discontinued financing activities
Financing cash flow
166.28%85.53M
151,704.17%36.43M
66,005.41%48.92M
112.08%36K
-99.57%140K
-32.79%32.12M
2,300.00%24K
-75.74%74K
89.23%-298K
-35.69%32.32M
Net cash flow
Beginning cash position
83.97%25.31M
264.76%46.69M
220.46%42.5M
345.02%45.09M
83.97%25.31M
80.20%13.76M
29.56%12.8M
-59.31%13.26M
-86.30%10.13M
80.20%13.76M
Current changes in cash
313.12%47.73M
110.64%26.36M
1,004.10%4.19M
-182.59%-2.59M
644.81%19.77M
88.67%11.55M
222.47%12.52M
97.96%-463K
107.57%3.13M
-105.47%-3.63M
End cash Position
188.56%73.05M
188.56%73.05M
264.76%46.69M
220.46%42.5M
345.02%45.09M
83.97%25.31M
83.97%25.31M
29.56%12.8M
-59.31%13.26M
-86.30%10.13M
Free cash flow
-70.85%-49.34M
-90.21%-13.06M
-38.85%-9.75M
-107.54%-12.58M
-56.23%-13.96M
37.94%-28.88M
30.14%-6.87M
42.34%-7.02M
42.80%-6.06M
35.89%-8.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -70.00%-49.04M-86.69%-12.78M-38.90%-9.75M-107.60%-12.57M-56.17%-13.95M37.86%-28.85M30.14%-6.84M42.29%-7.02M42.70%-6.05M35.75%-8.93M
Net income from continuing operations -51.88%-63.06M-40.82%-17.41M-26.31%-11.92M-38.48%-12.97M-100.51%-20.76M30.44%-41.52M9.17%-12.36M37.41%-9.44M41.64%-9.36M30.74%-10.35M
Operating gains losses ----------------------8K--0--0--------
Depreciation and amortization 8.57%114K30.77%34K0.00%25K7.69%28K-3.57%27K14.13%105K0.00%26K4.17%25K8.33%26K55.56%28K
Other non cash items 7.23%3.84M7.30%985K7.20%968K7.22%951K7.22%935K40.17%3.58M7.12%918K7.24%903K--887K--872K
Change In working capital -26.59%2.68M-98.04%63K-133.17%-69K-267.29%-1.89M609.12%4.58M194.13%3.66M182.86%3.22M126.36%208K-46.51%1.13M26.01%-899K
-Change in receivables -176.51%-1.12M-483.09%-2M43.48%495K158.74%158K-86.68%230K155.34%1.46M80.52%-343K166.99%345K-150.47%-269K292.96%1.73M
-Change in inventory ---648K------------------0----------------
-Change in prepaid assets -97.83%29K12.15%766K-125.80%-1.83M147.77%1.61M-163.24%-516K-52.67%1.34M-81.95%683K48.11%-810K1,280.85%649K46.24%816K
-Change in payables and accrued expense 406.51%4.43M-32.41%1.95M88.31%1.27M-585.77%-3.65M241.78%4.87M-15.54%875K418.47%2.88M-47.88%676K-50.59%752K-290.44%-3.43M
-Change in other working capital 29.41%-12K---1K-166.67%-8K--070.00%-3K-194.44%-17K--070.00%-3K-157.14%-4K-1,100.00%-10K
Cash from discontinued investing activities
Operating cash flow -70.00%-49.04M-86.69%-12.78M-38.90%-9.75M-107.60%-12.57M-56.17%-13.95M37.86%-28.85M30.14%-6.84M42.29%-7.02M42.70%-6.05M35.75%-8.93M
Investing cash flow
Cash flow from continuing investing activities 35.77%11.25M-86.02%2.7M-639.79%-34.98M4.87%9.94M224.32%33.58M74.16%8.28M41.37%19.33M159.69%6.48M133.83%9.48M-190.14%-27.01M
Net PPE purchase and sale -815.15%-302K-1,186.36%-283K50.00%-2K-57.14%-11K---6K70.54%-33K29.03%-22K77.78%-4K77.42%-7K--0
Net investment purchase and sale 38.86%11.55M-84.57%2.99M-639.43%-34.98M4.91%9.96M224.34%33.59M70.83%8.32M41.21%19.36M159.83%6.49M133.89%9.49M-190.05%-27.01M
Cash from discontinued investing activities
Investing cash flow 35.77%11.25M-86.02%2.7M-639.79%-34.98M4.87%9.94M224.32%33.58M74.16%8.28M41.37%19.33M159.69%6.48M133.83%9.48M-190.14%-27.01M
Financing cash flow
Cash flow from continuing financing activities 166.28%85.53M151,704.17%36.43M66,005.41%48.92M112.08%36K-99.57%140K-32.79%32.12M2,300.00%24K-75.74%74K89.23%-298K-35.69%32.32M
Net issuance payments of debt ----------------------0--0--0--0--0
Net common stock issuance 87.13%51.01M--4.95M--46.06M--0--0--27.26M--0--0---280K--27.54M
Proceeds from stock option exercised by employees 610.10%34.52M131,095.83%31.49M3,758.11%2.86M300.00%36K-97.07%140K746.86%4.86M2,300.00%24K-75.74%74K-220.00%-18K1,789.72%4.78M
Cash from discontinued financing activities
Financing cash flow 166.28%85.53M151,704.17%36.43M66,005.41%48.92M112.08%36K-99.57%140K-32.79%32.12M2,300.00%24K-75.74%74K89.23%-298K-35.69%32.32M
Net cash flow
Beginning cash position 83.97%25.31M264.76%46.69M220.46%42.5M345.02%45.09M83.97%25.31M80.20%13.76M29.56%12.8M-59.31%13.26M-86.30%10.13M80.20%13.76M
Current changes in cash 313.12%47.73M110.64%26.36M1,004.10%4.19M-182.59%-2.59M644.81%19.77M88.67%11.55M222.47%12.52M97.96%-463K107.57%3.13M-105.47%-3.63M
End cash Position 188.56%73.05M188.56%73.05M264.76%46.69M220.46%42.5M345.02%45.09M83.97%25.31M83.97%25.31M29.56%12.8M-59.31%13.26M-86.30%10.13M
Free cash flow -70.85%-49.34M-90.21%-13.06M-38.85%-9.75M-107.54%-12.58M-56.23%-13.96M37.94%-28.88M30.14%-6.87M42.34%-7.02M42.80%-6.06M35.89%-8.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -